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This study examined the association between consumption of alcoholic beverages and all-cause and cardiovascular disease (CVD)
mortality in a cohort of men (n = 31,367). In the Cox proportional hazards model adjusted for age, year of examination, body
mass index (BMI), smoking, family history of CVD, and aerobic ﬁtness, there were no signiﬁcant diﬀe r e n c e si nr i s ko fa l l - c a u s e
mortality across alcohol intake groups. Risk of CVD mortality was reduced 29% in quartile 1 (HR = 0.71, 95% conﬁdence interval
(CI): 0.53, 0.95) and 25% in quartile 2 (HR = 0.75, 95% CI: 0.58, 0.98). The amount of alcohol consumed to achieve this risk
reduction was <6 drinks/week; less than the amount currently recommended. The addition of other potential confounders and
eﬀect modiﬁers including blood pressure, insulin sensitivity, lipid levels, and psychological variables did not aﬀect the magnitude
of association. Future research is needed to validate the current public health recommendations for alcohol consumption.
1.Introduction
Light-to-moderate alcohol consumption has been shown in
several prospective studies to reduce the risk of all-cause
mortality and several cardiac outcomes, including cardio-
vascular disease (CVD) mortality in men [1–10]. Several
hypotheses exist for the mechanism of this protective eﬀect
including increased exposure to antioxidants, improved
lipid proﬁles, reduced insulin resistance, decreased blood
coagulation, and modiﬁed inﬂammation pathways [11, 12].
Despite a large number of studies examining alcohol
consumption and mortality, questions remain about the
nature of this relationship. Three primary concerns include
the inﬂuence of confounding factors, appropriate public
health recommendations, and diﬀerential eﬀects between
types of alcohol [13, 14]. Selection bias is a particular
concern when comparing nondrinkers to drinkers. Non-
drinkersmayabstainfromalcoholbecauseofaninitialhealth
condition and be more likely to have other conditions that
might confound the relationship including obesity, physical
inactivity, and overall health problems [14]. In addition,
moderate alcohol consumption has been associated with
positive psychosocial outcomes including sociability and
stressreduction,whichmayfurtherconfoundtheassociation
with mortality [15, 16]. Confounding is a limitation of
nonexperimental studies, yet it is unethical and impractical
toconductlong-termrandomizedcontrolledtrialsofalcohol
consumption. In an attempt to address this challenge,
investigators have used statistical methods to control for
possible confounders that may increase the risk of mortality
independent of alcohol consumption, but that may be
diﬀerentially distributed in those who drink alcohol versus
those who do not, such as smoking or physical inactivity.
S e v e r a lp r o b l e m sh a v eh a m p e r e dt h ea b i l i t yt oc o n s t r u c t
an appropriate public health message about alcohol con-
sumption. Methodological variation has led to inconsistent
estimates of protective amounts of alcohol and, thus, an
inability to quantify safe recommendations [17]. In addition,
any protective eﬀect must simultaneously be weighed against2 Journal of Aging Research
potential negative consequences. While several studies sup-
port light-to-moderate alcohol consumption as a protective
factor against CVD and all-cause mortality, excessive alcohol
intake has been associated with increased triglycerides, high
blood pressure, risk of some cancers, liver cirrhosis, heart
failure, and all-cause mortality [9, 12, 18]. Also, certain
cancers (e.g., breast) may be associated with increased risk
at low doses, but no dose response thereafter [19–21]. As
a result of these conﬂicting messages, the public may be
confused about the relationship between alcohol and health
outcomes.
The purpose of this study was to analyze the rela-
tionship between alcohol consumption and all-cause and
CVD mortality in a cohort of men while considering a
variety of potential confounding and modifying risk factors.
Additionally, diﬀerential eﬀects of types of alcohol on these
health outcomes were investigated.
2.MaterialsandMethods
2.1. Study Participants. Study participants were from the
Aerobics Center Longitudinal Study (ACLS) [22], a prospec-
tive epidemiological study of health outcomes in USA
adults. The sample for the current analyses was limited to
men, the majority of whom were white, middle to upper
income, received a baseline examination at the Cooper
Clinic in Dallas, Texas between 1974 and 2002 with at least
one year of followup, were aged ≥20 years at baseline,
were free of known CVD, cancer, or abnormal ECG, and
had complete information on alcohol intake and maximal
exercise treadmill test. Individuals participating in the ACLS
were either referred to the clinic by their employers or
physicians or through self-referral. The study was annually
reviewed and approved by the Cooper Institute Institutional
Review Board, and all participants gave written informed
consent for the baseline clinical examination and follow-up.
2.2. Primary Exposure Variable. Alcohol intake in drinks
per week among participants was self-reported at baseline.
Participants were asked, “How many 12-ounce drinks of
beer, 3-ounce drinks of wine (5-ounce drinks of wine during
more recent data collection cycles), and/or 1.5-ounce drinks
of hard liquor do you consume per week?” Self-report
alcohol intake has been previously validated against dietary
records in men (r = 0.86) [23, 24]. Participants were then
classiﬁed either as nondrinkers, or in quartiles of drinkers
based on baseline alcohol drinking reports.
2.3. Outcome Variables. All participants were followed from
the date of their baseline examination until their death or
December 31, 2003. Mortality surveillance was primarily
through the National Death Index. CVD mortality was
deﬁned as the International Classiﬁcation of Diseases, Ninth
Revision codes 390 to 449.9 before 1999 and Tenth Revision
codes I00 to I78 during 1999–2003.
2.4. Covariates. The baseline clinical assessment has been
previously described in detail [22, 25, 26]. At the baseline
visit patients completed a written survey and anthropomet-
ric, blood pressure, blood chemistry, and electrocardiogram
measures.BodyMassIndex[BMI=weight(kg)/height(m)2]
was calculated from height and weight. Resting blood pres-
surewasassessedviaascultatorymethod[27].Bloodsamples
were drawn after a 12-hour overnight fast, and analyzed for
fasting glucose and cholesterol using automated bioassays
according to the Centers for Disease Control and Prevention
Lipid Standardization Program. Hypertension, hypercholes-
terolemia, and diabetes were deﬁned according to clinical
thresholds or self-reported as a previous diagnosis from
a physician. Hypertension was deﬁned as resting systolic
or diastolic blood pressure ≥140/90mmHg, hypercholes-
terolemia was deﬁned as total cholesterol ≥240mg/dL [28],
anddiabeteswasdeﬁnedasfastingglucose ≥126mg/dL[29].
The questionnaire included questions on smoking habits,
family history of CVD, and the presence of neuropsychiatric
conditions including anxiety, depression, suicidal thoughts,
or psychological counseling. Cardiorespiratory ﬁtness (CRF)
was assessed using symptom-limited maximal treadmill
time during the modiﬁed Balke Protocol [22, 30]. Test
termination occurred by participant volition or physician
determined medical reasons. Test duration has been strongly
correlated with maximal oxygen uptake (r = 0.92) [31].
Cardiorespiratory ﬁtness is a quantiﬁable, objective measure
with stronger associations to future health outcomes than
self-reported physical activity [32]. Treadmill times were
classiﬁedintoﬁtnessquintileswiththeﬁrstquintileclassiﬁed
as unﬁt and the remaining four quintiles as ﬁt [33].
2.5. Statistical Analysis. Cox proportional hazards models
were used to calculate hazard ratios (HRs) and associated
95% conﬁdence intervals. Alcohol consumption was the
primary exposure of interest. All-cause and CVD mortality
were ﬁt as the outcomes (i.e., death or not, and time to event
or censoring) for survival analysis. Nondrinkers were used
as the referent group and those classiﬁed as drinkers were
categorized into quartiles of exposure. Linear and quadratic
trends were tested by ﬁtting the continuous variable of
alcohol consumption in the basic model for both all-cause
and cardiovascular disease mortality. The basic model was
adjusted for age (in years), year of examination, BMI,
smoking (current smoker or not), family history of CVD
(yes or no), and treadmill time (minutes). Because blood
pressure [34], insulin sensitivity [35], and lipid levels [36]
havebeenshowntomediatetherelationshipbetweenalcohol
and CVD mortality, they were added individually and then
simultaneously into the basic model. Finally, the full model
was adjusted for psychological variables [15, 16].
To examine eﬀect modiﬁcation due to other health
risk factors, multivariate stratiﬁed analyses were conducted
for dichotomies based on age (<60 and ≥60 years), BMI
(<25 and ≥25kg/m2), health status (healthy and unhealthy
deﬁned as having at least one of the following diseases:
hypertension, diabetes, or hyperlipidemia), and ﬁtness (least
ﬁt 20% and most ﬁt 80%) to test for eﬀect modiﬁcation.
These models were adjusted for year of examination, smok-
ing, family history of CVD, and age, BMI, health status, and
ﬁtness where appropriate.Journal of Aging Research 3
After analyzing the overall eﬀect of alcohol on mortality,
separate analyses were run for each type of alcohol (beer,
wine, and liquor), because of the potential diﬀerential eﬀects
from diﬀerent types of alcohol. As there were few men who
consumed a single beverage type, analysis was conducted
separately for quartiles of a single type of alcohol while
adjusting for the remaining type of alcohol consumption
[37, 38]. Alcohol consumption quartiles were created inde-
pendently for each alcohol type and hazard ratios adjusted
for age, year of examination, BMI, smoking, family history
of CVD, maximal treadmill time, and remaining types of
alcohol were calculated using nondrinkers as the reference
group.
3. Results andDiscussion
Atotalof31,637menwereincludedinthesample.Themean
age of men at baseline was 42.9 (standard deviation (SD):
9.2) years. Baseline characteristics are presented in Table 1.
Mean follow-up time was 16.0 (8.3) years for a total
of 504,735 person-years. There were 1,834 total deaths
and 588 CVD deaths. The rate of all-cause and CVD
mortality was calculated for the ﬁve drinking categories:
nondrinkers, quartile 1 (1–3 drinks/week), quartile 2 (4–6
drinks/week), quartile 3 (7–13 drinks/week), and quartile
4( ≥14 drinks/week). Alcohol consumption was linearly
associated with both all-cause and CVD mortality rate (P =
0.002 and P = 0.02).
3.1. Primary Analysis. In the basic model adjusted for age,
year of examination, BMI, smoking, family history of CVD,
and ﬁtness, there were no signiﬁcant diﬀerences in all-cause
mortality risks across alcohol intake groups (Table 2). There
was a lower risk of CVD mortality in quartile 1 (HR = 0.71,
95% conﬁdence interval (CI): 0.53, 0.95) and quartile 2 (HR
= 0.75, 95% CI: 0.58, 0.98) in the basic model which is
less than 6 drinks per week (see Table 3). The addition of
potential intermediate variables of glucose, lipids, and blood
pressure, or the inclusion of all three, did not attenuate these
relationships. The additional adjustment for psychological
variables did not alter the observed associations and are not
included in the results presented.
3.2. Stratiﬁed Analysis. The lower risk of all-cause mortality
from light drinking (quartile 1) was attenuated when the
results were stratiﬁed by BMI, health status, and ﬁtness (see
Table 4). However, men younger than 60 years in quartile 1
exhibited a signiﬁcantly lower risk of all-cause mortality (HR
=0.80,95%CI:0.66,0.96);whereas,men60orolderdidnot.
For CVD mortality, there were no signiﬁcant ﬁndings
in men who were ≥60 years, had a BMI < 25kg/m2,w e r e
healthy, or unﬁt (see Table 5). Younger men had lower risk of
CVD mortality in quartile 1 (HR = 0.59, 95% CI: 0.43, 0.83)
and quartile 2 (HR = 0.70, 95% CI: 0.52, 0.93). Men with a
BMI >25kg/m2 had lower CVD mortality risk in quartile 1
(HR = 0.67, 95% CI: 0.47, 0.94) and quartile 2 (HR = 0.71,
95% CI: 0.52, 0.97). Unhealthy men had a reduced risk in
quartile 3 (HR = 0.74, 95% CI: 0.54, 0.998). When stratiﬁed
by ﬁtness, ﬁt men exhibited a lower risk in quartile 2 (HR =
0.69, 95% CI: 0.49, 0.96).
3.3. Type of Alcohol. The results of the sensitivity analysis are
listed in Table 4. There were a total of 26,767 drinkers, of
which 23,728 reported drinking beer, 21,997 reported drink-
ing wine, and 20,416 reported drinking liquor. Therefore, for
this analysis, the types of alcohol drinking are not exclusive.
For all-cause mortality, there were no signiﬁcant diﬀerences
in risk for any three of the alcohol types in comparison to
nondrinkers (see Table 6). For CVD mortality, there was a
lower risk with beer consumption in quartile 3 (HR = 0.72,
95% CI: 0.52, 0.995), wine consumption in quartile 2 (HR =
0.70, 95% CI: 0.53, 0.93) and liquor consumption in quartile
2( H R= 0.71, 95% CI: 0.50, 0.93) and Q3 (HR = 0.69, 95%
CI: 0.55, 0.93) (see Table 7).
4. Discussion
4.1. All-Cause Mortality. In the current study, the rela-
tionship between risk of all-cause mortality with alcohol
consumption appeared to evince a ﬂattened J-shaped curve
pattern. However, the risk reductions were signiﬁcant only
at the lowest levels of alcohol consumption. Other studies
reporting on the association of alcohol consumption and
all-cause mortality in men have found protective eﬀects up
to three drinks per day [5]. In the Physicians Health Study,
Gaziano et al [3] ,f o u n dar e d u c t i o ni na l l - c a u s em o r t a l i t y
with 5 to 6 drinks/week and reductions in CVD mortality
with all levels of alcohol consumption. Gaziano’s results are
consistentwithameta-analysisconductedbyDiCastelnuovo
[39] which found a reduced risk for all-cause mortality up to
4 drinks per day.
4.2. Cardiovascular Disease Mortality. It has been hypoth-
esized that the lower CVD mortality risk associated with
limited alcohol intake is due to the cardioprotective eﬀects of
alcohol such as improved lipid proﬁles and decreased blood
coagulation [11, 12]. CVD contributes to 34.3% of all deaths
in the nation and is an important health outcome [40];
therefore, our results warrant consideration. In this sample,
32% of all deaths were attributed to CVD, similar to the
nationwide estimates. There was a 29% and 25% reduction
in risk for CVD mortality in the ﬁrst and second quartiles of
alcohol consumption, respectively. This risk reduction was
found for 1–6 drinks per week. The lower risk of CVD death
may be balanced with an increase in other causes of death
potentially due to alcohol consumption, again complicating
public health recommendations.
ThelowerCVDmortalityriskweobservedwasnotatten-
uated when potential intermediate factors of blood pressure,
lipids, and glucose were added to the model, suggesting the
lower risks were not mediated by these factors. While Suh et
al. [7] and Djouss´ e et al. [41] found that the reduced risk of
CVD mortality in women was mediated by lipids and insulin
sensitivity, other authors have found the relationship to be
independent of these risk factors. Arriola et al. [1]f o u n d
that blood pressure, cholesterol, and diabetes did not alter4 Journal of Aging Research
Table 1: Baseline demographics by alcohol consumption level, Aerobics Center for Longitudinal Study (ACLS), 1974–2002.
Alcohol consumption (drinks/week)
Nondrinkers (0) Quartile 1 (1–3) Quartile 2 (4–6) Quartile 3 (7–13) Quartile 4 (≥14)
n 4870 6733 6150 6841 7043
Age (years) 43.63 (9.65) 42.15 (9.15) 42.34 (9.07) 42.95 (9.23) 43.62 (9.13)
Alcohol (drinks/week) 0 2.01 (0.76) 5.00 (0.87) 9.65 (1.93) 24.62 (13.64)
Body mass index (kg/m2) 26.65 (4.29) 26.63 (4.02) 26.36 (3.65) 26.28 (3.45) 26.42 (3.35)
Maximal treadmill time (min) 17.24 (5.15) 18.33 (4.89) 18.14 (4.90) 18.50 (4.84) 17.78 (4.83)
Current smokers (%) 10.62 14.18 19.50 22.03 29.09
Systolic blood pressure (mmHg) 121 (13) 121 (13) 121 (13) 121 (13) 122 (13)
Diastolic blood pressure (mmHg) 81 (10) 80.91 (9.47) 80.52 (9.35) 81.17 (9.41) 81.90 (9.53)
Hypertension (%)a 30.86 28.32 28.10 30.35 34.49
Fasting glucose (mg/dL) 99.14 (18.92) 99.20 (16.52) 98.80 (14.50) 99.74 (14.50) 101.13 (14.19)
Diabetes (%)b 4.58 4.92 4.70 4.37 4.91
Total cholesterol (mg/dL) 205.80 (38.56) 203.21 (39.88) 205.42 (38.29) 209.58 (39.16) 217 (40.42)
Triglycerides (mg/dL) 141.09 (104.59) 137.20 (106.77) 132.02 (94.37) 134.63 (101.78) 144.54 (105.24)
Hyperlipidemia (%)c 29.49 26.56 26.03 28.46 35.57
Unhealthy (%)d 49.63 46.81 45.69 48.68 55.93
Family history of CVD (%) 26.96 23.91 25.45 24.69 28.44
aDeﬁned as systolic or diastolic blood pressure ≥140/90mmHg or history of physician diagnosis.
bDeﬁned as fasting glucose ≥126mg/dl or history of physician diagnosis.
cDeﬁned as fasting total cholesterol ≥240mg/dl or triglyceride ≥200mg/dL.
dDeﬁned as presence of one or more of following diseases: hypertension, diabetes, or hyperlipid.
Table 2: Hazard ratios of all-cause mortality by alcohol consumption level in men, Aerobics Center for Longitudinal Study (ACLS), 1974–
2002.
Alcohol consumption (drinks/week)
Nondrinkers (0) Quartile 1 (1–3) Quartile 2 (4–6) Quartile 3 (7–13) Quartile 4 (≥14)
Person-years 86,872 91,529 98,303 103,625 124,360
No. 4870 6733 6150 6841 7043
No. of Deaths 343 237 350 349 555
Death ratea 43.8 37.2 43.3 41.6 51.2
Basic modelb 1.00 (referent) 0.86 (0.73–1.01) 0.95 (0.82–1.10) 0.97 (0.83–1.12) 1.09 (0.95–1.25)
Basic model plus
Blood pressure factorsc 1.00 (referent) 0.86 (0.73–1.02) 0.94 (0.81–1.09) 0.97 (0.83–1.12) 1.06 (0.92–1.21)
Fasting glucose factorsd 1.00 (referent) 0.84 (0.71–0.99) 0.95 (0.82–1.10) 0.96 (0.82–1.11) 1.07 (0.94–1.23)
Lipid factorse 1.00 (referent) 0.86 (0.73–1.01) 0.95 (0.82–1.11) 0.96 (0.83–1.12) 1.09 (0.95–1.25)
All intermediate factorscde 1.00 (referent) 0.84 (0.71–0.99) 0.94 (0.81–1.09) 0.96 (0.82–1.11) 1.05 (0.91–1.20)
aDeath rate per 10,000 person-years adjusted for age (in years).
bAdjusted for age (in years), year of examination, BMI (kg/m2), smoking (current smoker or not), family history of CVD (yes or no), and maximal treadmill
time (min).
cSystolic blood pressure and reported hypertension (yes or no).
dFasting glucose and reported diabetes (yes or no).
eTotal cholesterol and triglyceride.
their results and, through coronary angiography, Femia et al.
[42] found the risk for atherosclerosis and cardiac mortality
was independent of cholesterol, hypertension, and diabetes.
More research is needed to study the potential mechanisms
of alcohol intake on reduced CVD mortality risk.
4.3. Public Health Recommendations. Our results do not
support the currently recommended intake of 1-2 drinks
per day for men from the American Heart Association [43].
The lower alcohol consumption for risk reduction in our
study may result from complete adjustment for confounders
including ﬁtness and thorough screening resulting in exclu-
sion of preclinical cases. There are large variations in results
from prospective studies examining alcohol consumption
and mortality making it diﬃcult to compare ﬁndings for
universal alcohol recommendations. In Di Castelnuovo et
al.’s [39] meta-analysis of all-cause mortality, they found
diﬀerences among genders, countries of the study, and
number of confounders. There has been large variation in
methodsofreportingandcategorizingalcoholconsumption.Journal of Aging Research 5
Table 3: Hazard ratios of CVD mortality by alcohol consumption level in men, Aerobics Center for Longitudinal Study (ACLS), 1974–2002.
Alcohol consumption (drinks/week)
Nondrinkers (0) Quartile 1 (1–3) Quartile 2 (4–6) Quartile 3 (7–13) Quartile 4 (≥14)
Person-years 86,872 91,529 98,303 103,625 124,360
No. 4742 6663 6049 6735 6860
No. of Deaths 128 70 101 106 183
Death ratea 17.0 11.6 13.1 12.9 17.7
Basic modelb 1.00 (referent) 0.71 (0.53–0.95) 0.75 (0.58–0.98) 0.83 (0.64–1.08) 1.00 (0.80–1.26)
Basic model plus
Blood pressure factorsc 1.00 (referent) 0.70 (0.53–0.94) 0.73 (0.56–0.95) 0.84 (0.64–1.09) 0.94 (0.75–1.18)
Fasting glucose factorsd 1.00 (referent) 0.68 (0.51–0.91) 0.75 (0.58–0.98) 0.82 (0.63–1.07) 0.98 (0.78–1.24)
Lipid factorse 1.00 (referent) 0.71 (0.53–0.95) 0.73 (0.56–0.96) 0.80 (0.62–1.04) 0.95 (0.75–1.19)
All intermediate factorscde 1.00 (referent) 0.68 (0.51–0.91) 0.71 (0.55–0.93) 0.81 (0.62–1.05) 0.88 (0.69–1.11)
aDeath rate per 10,000 person-years adjusted for age (in years).
bAdjusted for age (in years), year of examination, BMI (kg/m2), smoking (current smoker or not), family history of CVD (yes or no), and maximal treadmill
time (min).
cSystolic blood pressure and reported hypertension (yes or no).
dFasting glucose and reported diabetes (yes or no).
eTotal cholesterol and triglyceride.
Table 4: Hazard ratios of all-cause mortality stratiﬁed by risk factorsa, Aerobics Center for Longitudinal Study (ACLS), 1974–2002.
Alcohol consumption (drinks/week)
Nondrinkers (0) Quartile 1 (1–3) Quartile 2 (4–6) Quartile 3 (7–13) Quartile 4 (≥14)
Age
Age <60 (n = 30,263) 1.00 (referent) 0.80 (0.66–0.96) 0.92 (0.78–1.09) 1.02 (0.86–1.20) 1.08 (0.93–1.26)
Age ≥60 (n = 1,374) 1.00 (referent) 0.86 (0.59–1.25) 0.85 (0.59–1.23) 0.75 (0.52–1.08) 1.04 (0.76–1.44)
BMI
BMI <25 (n = 12,037) 1.00 (referent) 0.85 (0.65–1.11) 1.03 (0.80–1.32) 0.95 (0.74–1.22) 0.97 (0.77–1.23)
BMI ≥25 (n = 19,600) 1.00 (referent) 0.86 (0.70–1.06) 0.90 (0.75–1.09) 0.96 (0.79–1.16) 1.12 (0.95–1.33)
Health statusb
Healthy (n = 15,989) 1.00 (referent) 0.91 (0.69–1.20) 0.92 (0.71–1.19) 1.10 (0.86–1.42) 1.11 (0.87–1.41)
Unhealthy (n = 15,648) 1.00 (referent) 0.82 (0.67–1.01) 0.97 (0.81–1.17) 0.88 (0.73–1.07) 1.05 (0.89–1.24)
Fitness level
Unﬁt (least ﬁt 20%) (n = 5,238) 1.00 (referent) 0.91 (0.67–1.22) 1.02 (0.79–1.32) 1.10 (0.83–1.44) 1.17 (0.92–1.48)
Fit (most ﬁt 80%) (n = 26,399) 1.00 (referent) 0.84 (0.69–1.03) 0.91 (0.76–1.10) 0.87 (0.73–1.05) 1.01 (0.85–1.19)
aAdjusted for year of examination, smoking (current smoker or not), family history of CVD (yes or no), and each other factor in the table.
bDeﬁned as presence or absence of one or more of following diseases: hypertension, diabetes, or hyperlipidemia.
Various authors have used diﬀerent deﬁnitions of drinks
ranging from 8 grams of alcohol per drink [10] to 22.8
grams [6]. Therefore, we did not attempt to impose grams of
alcohol conversion factors on self-reported drinks per week.
Thereisadditionalcomplexitywhenlookingatthemyriadof
cardiovascular outcomes. Previous studies have used various
outcomes including CVD mortality, cardiac mortality, CHD,
and myocardial infarction. For example, Beulens et al. [37]
found a reduction in risk of myocardial infarction, but not
in all-cause or CVD mortality. Due to such variation, it is
challenging to establish widespread recommendations for a
safe or protective amount of alcohol consumption as related
to CV health.
While a decrease in risk of all-cause mortality with
alcoholconsumptionwasnotfoundinthissample,therewas
not a signiﬁcantly increased risk with the highest amounts
of self-reported alcohol consumption. Klatsky [12]d e ﬁ n e d
heavy drinking as greater than 3 drinks per day, which is
consistent with the mean 24 drinks per week found in the
highest quartile of alcohol consumption in this study. While
our sample did not show a higher risk of either all-cause
or CVD mortality with the highest alcohol consumption,
there are other concerns in recommending drinking alcohol
including potential alcohol abuse. Rehm et al. [44]e s t i m a t e d
12.1% of disability-adjusted life years for men in the US were
attributed to alcohol-related causes with an estimated cost
of $235 billion dollars. Of problem drinkers, 82% report
drinking the moderate amount recommended to protect
against CVD [17]. Alcohol may be harmful in many ways,
even in small amounts (e.g., as a cocarcinogen with tobacco
smoke) [45].6 Journal of Aging Research
Table 5: Hazard ratios of CVD mortality stratiﬁed by risk factorsa, Aerobics Center for Longitudinal Study (ACLS), 1974–2002.
Alcohol consumption (drinks/week)
Nondrinkers (0) Quartile 1 (1–3) Quartile 2 (4–6) Quartile 3 (7–13) Quartile 4 (≥14)
Age
Age < 60 (n = 30,263) 1.00 (referent) 0.59 (0.43–0.83) 0.70 (0.52–0.93) 0.78 (0.58–1.04) 0.85 (0.66–1.11)
Age ≥ 60 (n = 1,374) 1.00 (referent) 1.07 (0.57–2.00) 0.82 (0.43–1.57) 1.06 (0.59–1.91) 1.53 (0.92–2.54)
BMI
BMI < 25 (n = 12,037) 1.00 (referent) 0.80 (0.47–1.37) 0.84 (0.51–1.39) 0.76 (0.46–1.25) 1.02 (0.66–1.59)
BMI ≥ 25 (n = 19,600) 1.00 (referent) 0.67 (0.47–0.94) 0.71 (0.52–0.97) 0.82 (0.60–1.11) 0.91 (0.69–1.19)
Health statusb
Healthy (n = 15,989) 1.00 (referent) 0.61 (0.32–1.16) 0.73 (0.42–1.28) 1.06 (0.63–1.79) 1.18 (0.72–1.92)
Unhealthy (n = 15,648) 1.00 (referent) 0.73 (0.52–1.01) 0.76 (0.56–1.02) 0.74 (0.54–0.998) 0.90 (0.69–1.17)
Fitness level
Unﬁt (least ﬁt 20%) (n = 5,238) 1.00 (referent) 0.65 (0.39–1.08) 0.80 (0.52–1.22) 0.80 (0.50–1.27) 1.00 (0.68–1.44)
Fit (most ﬁt 80%) (n = 26,399) 1.00 (referent) 0.72 (0.51–1.04) 0.69 (0.49–0.96) 0.73 (0.53–1.00) 0.89 (0.67–1.19)
aAdjusted for year of examination, smoking (current smoker or not), family history of CVD (yes or no), and each other factor in the table.
bDeﬁned as presence or absence of one or more of following diseases: hypertension, diabetes, or hyperlipidemia.
Table 6: Hazard ratios of all-cause mortality stratiﬁed by types of alcohol beveragea, Aerobics Center for Longitudinal Study (ACLS), 1974–
2002.
Alcohol consumption (drinks/week)
Nondrinkers Quartile 1 Quartile 2 Quartile 3 Quartile 4
Beer (n = 23,728)
No. 4870 3854 4876 5779 4349
No. of Cases 343 147 362 227 237
Hazard ratios 1.00 (referent) 0.87 (0.71, 1.06) 0.99 (0.84, 1.16) 0.90 (0.75, 1.07) 1.15 (0.96, 1.37)
Wine (n = 21,997)
No. 4870 4091 4999 4175 3862
No. of Cases 343 177 370 183 196
Hazard ratios 1.00 (referent) 0.87 (0.72, 1.05) 0.92 (0.79, 1.08) 0.88 (0.73, 1.07) 0.95 (0.78, 1.14)
Liquor (n = 20,416)
No. 4870 3111 5022 3562 3851
No. of Cases 343 126 383 247 423
Hazard ratios 1.00 (referent) 0.93 (0.75, 1.14) 0.96 (0.82, 1.12) 0.89 (0.75, 1.06) 1.13 (0.97, 1.32)
ACLS: Aerobics Center Longitudinal Study.
aAdjusted for age (in years), year of examination, BMI (kg/m2), smoking (current smoker or not), family history of CVD (yes or no), maximal treadmill time
(min), and remaining type of alcohol.
4.4. Stratiﬁed Analysis. The lower risk for all-cause mortality
was attenuated when stratiﬁed by BMI and health status,
but remained signiﬁcant in younger men, consistent with
stratiﬁed results found by Sun et al. [8]. A meta-analysis
by Hvidtfeldt et al. [46] found a reduced risk of coronary
heart disease in all ages, and our null ﬁndings in the older
age group may be due to unequal sample size distributions
for each level, reducing power in the sparser strata. The
lower risk of CVD mortality in the current study remained
in younger, overweight, unhealthy, and ﬁt men. Similarly,
the protective eﬀect of alcohol consumption has been shown
in populations with poor health status including men with
hypertension [37], cardiovascular disease [47], and vascular
disease including diabetes mellitus [2].
Interestingly, when the data were analyzed by ﬁtness
levels, ﬁt men had lower risks of CVD mortality with larger
alcohol consumption than did unﬁt men. This may be due
to a synergistic eﬀect as alcohol and ﬁtness aﬀect similar
pathways such as lipid, glucose, and cholesterol metabolism.
It also may be due to ﬁt nondrinkers having a higher risk due
to other latent variables (they may have been high risk and
as a result began to exercise and quit drinking). The diﬀerent
risks associated with stratiﬁed populations conﬁrm that the
relationship between alcohol and mortality is complex and
m a yv a r yb e t w e e np o p u l a t i o ns u b g r o u p s .
4.5. Type of Alcohol. The results of the sensitivity analysis
found no signiﬁcant changes in risk of all-cause mortality
when alcohol consumption was stratiﬁed by type, consistent
with the overall analysis. Although for CVD mortality,
our ﬁndings suggest that there was a reduction in risk
of about 29% for moderate consumption of beer, wine,
and liquor. This reduction was most consistent with liquorJournal of Aging Research 7
Table 7:HazardratiosofCVDmortalitystratiﬁedbytypesofalcoholbeveragea,AerobicsCenterforLongitudinalStudy(ACLS),1974–2002.
Alcohol consumption (drinks/week)
Non Drinkers Quartile 1 Quartile 2 Quartile 3 Quartile 4
Beer (n = 23,728)
No. 4870 3854 4876 5779 4349
No. of Cases 128 43 104 64 75
Hazard ratios 1.00 (referent) 0.71 (0.50, 1.02) 0.76 (0.57, 1.01) 0.72 (0.52,0.995) 1.06 (0.78, 1.45)
Wine (n = 21,997)
No. 4870 4091 4999 4175 3862
No. of Cases 128 55 104 55 64
Hazard ratios 1.00 (referent) 0.76 (0.55, 1.05) 0.70 (0.53,0.93) 0.74 (0.53, 1.04) 0.89 (0.64, 1.23)
Liquor (n = 20,416)
No. 4870 3111 5022 3562 3851
No. of Cases 128 36 112 74 144
Hazard ratios 1.00 (referent) 0.74 (0.51, 1.07) 0.71 (0.55,0.93) 0.69 (0.50,0.93) 0.98 (0.75, 1.27)
aAdjusted for age (in years), year of examination, BMI (kg/m2), smoking (current smoker or not), family history of CVD (yes or no), maximal treadmill time
(min), and remaining type of alcohol.
consumption. Beulens et al. [37] also found that liquor
drinkers had the strongest association with decreased risk
of myocardial infarction. There have been inconsistencies,
however, when comparing the types of alcohol on mortality.
While several epidemiologic studies, including the current
study, have found no diﬀerences in risk between types of
alcohol consumed [1, 43, 48, 49], others have suggested
unique cardioprotection from wine [50]. Experimental stud-
ies have shown the ethanol in wine to have additional
protection compared to dealcoholized red wine [51]. The
diﬀerential eﬀects may depend on gender. Compared to de-
alcoholizedbeverages,womenhadincreasedadiponectin(an
anti-inﬂammatory factor also shown to be associated with
improved insulin sensitivity) after drinking red wine, while
men had increased levels after drinking liquor and beer [52].
4.6. Strengths and Limitations. Strengths of this study are
inclusion of several potential confounders including mea-
sures of ﬁtness and psychological variables, lengthy follow-
up in a large cohort, exploration of relationships by health
risk factors, and stratiﬁcation by alcohol types. The lim-
itations include that the sample was only men from the
Cooper Clinic in Dallas, Tex, USA, predominantly white,
and of middle to high incomes, limiting generalizations to
entire populations. However, the homogenous population
does eliminate potential confounding from gender [4]a n d
race [5, 28], both of which have been shown to inﬂuence
the relationship between alcohol and mortality. Additionally,
this regional population is similar in physiologic variables
to other North American populations [53]. The mean age
of 43 at baseline with an average follow-up time of 16
years makes these ﬁndings particularly relevant for an aging
American population. When stratiﬁed by age, we did not
ﬁnd a signiﬁcant association in the older men, but this may
have been due to a small sample of men above 60. Future
studies are needed to conﬁrm the lower levels of alcohol
consumptionfoundtobeprotectiveinthisstudypopulation.
Clearly,moreworkwillberequired in populations thatdiﬀer
in racial and ethnic composition to that of the ACLS.
While self-reported alcohol consumption has been val-
idated [23], under or overreporting could have inﬂuenced
the trends in risk reduction in either direction. The format
of response did not allow assessment of varied drinking
patterns including daily frequency of alcohol consumption.
Studies have suggested that alcohol should be consumed in
small amounts over multiple occasions for health beneﬁts
rather than binge drinking [54]. In the sensitivity analyses,
it was not possible to isolate single types of drinkers due to
low prevalence of single alcohol-type drinkers.
Despite adjustment for many confounders, confounding
may still exist in this and other prospective studies. One
potential confounder not adjusted for was diet, particularly
fat intake, which plays an established role in cardiovascular
outcomes. We did, however, measure and control for blood
cholesterol levels which is associated with dietary fat intake
[55].
Consistent with previous studies, we used nondrinkers
as the referent group [5, 43, 56]. Some researchers have
argued against using nondrinkers as the referent group due
to confounding predisposing conditions or other latent vari-
ables contributing to diﬀerential mortality risk independent
of alcohol consumption [10]. Mukamal et al. [14]f o u n d
that nondrinkers are more likely to be in poor health,
obese, of low income, or physically inactive; however, they
did not exclude or report whether the participants had
preexisting vascular disease. In contrast, when adjusted for
preexistingdisease(excludedorcontrolledforinourmodel),
Wannamethee and Shaper [10] found ex-drinkers and life-
longnondrinkers hadequalCVDmortalityandalmostequal
all-cause mortality. When Hart and Smith [56] examined
the health status of nondrinkers to drinkers, they did not
diﬀersubstantially.Friesemaetal.[57]foundthattheinverse
relationship between alcohol consumption and mortality
could not be explained by health status alone. Potential
confoundingwouldhavealesslikelyeﬀectonCVDmortality8 Journal of Aging Research
as Klatsky and Udaltsova [5] found that the excess mortality
seen in nondrinkers is not related to CVD.
This study attempted to account for any “sick quitters”
(former drinkers who stopped due to an adverse health
condition) through in-depth baseline assessments to rule
out underlying disease and adjustment for confounders. In
asymptomatic men, especially with risk factors for CVD,
exercise testing has been shown to be a valid predictor of
future CVD mortality [58] beyond reported risk factors [59].
In addition, we examined if the risk association varied by
levelsoftheseriskfactors(healthstatus,age,BMI,andﬁtness
status).
5. Conclusion
We found a trend towards reduction in risk of all-cause
mortality with self-reported alcohol consumption and a
reduction in risk of CVD mortality with one to six drinks per
week, when adjusting for several potential confounders in a
large sample of men. The amount of alcohol consumption
associatedwithareducedriskofCVDmortalitywaslessthan
the current public health recommendations of 1-2 drinks
per day. A lack of consensus on the amount and type of
alcohol for protective eﬀects and other potential harmful
consequencesofalcoholabusecallsforcautionwhenmaking
public health recommendations for alcohol consumption.
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